Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes

The Pharmacogenomics Journal
Jihoon ChoiQing Ling Duan

Abstract

More than 1100 genetic loci have been correlated with drug response outcomes but disproportionately few have been translated into clinical practice. One explanation for the low rate of clinical implementation is that the majority of associated variants may be in linkage disequilibrium (LD) with the causal variants, which are often elusive. This study aims to identify and characterize likely causal variants within well-established pharmacogenomic genes using next-generation sequencing data from the 1000 Genomes Project. We identified 69,319 genetic variations within 160 pharmacogenomic genes, of which 8207 variants are in strong LD (r2>0.8) with known pharmacogenomic variants. Of the latter, eight are coding or structural variants predicted to have high impact, with 19 additional missense variants that are predicted to have moderate impact. In conclusion, we identified putatively functional variants within known pharmacogenomics loci that could account for the association signals and represent the missing causative variants underlying drug response phenotypes.

References

Dec 14, 2001·AAPS PharmSci·L MancinelliW Sadée
Dec 26, 2001·Nucleic Acids Research·Micheal HewettTeri E Klein
Dec 26, 2001·Nucleic Acids Research·Ron EdgarAlex E Lash
Apr 19, 2003·Cleveland Clinic Journal of Medicine·Amir Jaffer, Lee Bragg
Dec 19, 2003·Nucleic Acids Research·Donna KarolchikW James Kent
May 28, 2004·Nature·William E Evans, Mary V Relling
Mar 22, 2005·American Journal of Respiratory and Critical Care Medicine·Michael E Wechsler, Elliot Israel
Feb 9, 2010·Pharmacogenomics·Wei Zhang, M Eileen Dolan
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V Relling, T E Klein
Sep 9, 2011·Clinical Pharmacology and Therapeutics·J A JohnsonUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Dec 6, 2011·Nucleic Acids Research·Michael Cariaso, Greg Lennon
Sep 8, 2012·Genome Research·Alan P BoyleMichael Snyder
Sep 21, 2012·Clinical Pharmacology and Therapeutics·M Whirl-CarrilloT E Klein
Sep 29, 2012·Science Translational Medicine·Kathleen M GiacominiYusuke Nakamura
Apr 17, 2013·Clinical Pharmacology and Therapeutics·A R ShuldinerChristopher G Chute
Apr 5, 2014·BioMed Research International·Thomas Van den BroeckFrank Claessens
Oct 4, 2015·Nature·UNKNOWN 1000 Genomes Project ConsortiumGonçalo R Abecasis

❮ Previous
Next ❯

Methods Mentioned

BETA
X-Ray
ChIP-seq
genotyping

Software Mentioned

SNPEff
SNPedia
Plink
VEP
SIFT
annoVar
CADD
Polyphen
RegulomeDB

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.